THERANEXUS ANNOUNCES FIRST HALF 2023 FINANCIAL RESULTS
Lyon, France – 28 September 2023 – 6pm CEST – Theranexus, a biopharmaceutical company innovating in the treatment of rare neurological.
This alternating pattern of wet and dry periods is believed to have created an environment conducive to the development of complex ancient organic compounds. These compounds could have acted as precursors to life, indicating that Mars could have hosted conditions suitable for life s emergence.